Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 233

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 233
---
 linked to the R&D pipeline has been included inthe Chief Executive Officer's equity-based compensation plan.•Clawback Policy:–Pursuant to the NASDAQ listing rules as amended in 2023,  onOctober 26, 2023, our Board of Directors adopted a clause allowingthe clawback, in full or in part, of compensation paid to the ChiefExecutive Officer wholly or partly contingent on the attainment offinancial criteria based on erroneous financial information. |

| SANOFIFORM 20-F2024 | 133 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

Arrangements in favor of executive officers in office as of December 31, 2024 (table No. 11 of the AFEP-MEDEF Code)

| Executive officer       | Contract ofemployment | Top-uppension plan | Indemnities or benefitspayable orpotentially payableon cessation of office | Indemnitiespayable undernon-compete clause |
| Chairman of the Board   | No                    | No                 | No                                                                         | No                                         |
| Chief Executive Officer | No                    | Yes                | Yes                                                                        | Yes                                        |

Compensation and benefits of all kinds awardable to corporate officers in respect of 2025 The section below describes the components of the compensation and benefits of all kinds awardable to corporate officers in respect of the 2025 financial year, pursuant to the compensation policies described in “— Compensation policy for corporate officers” above. Compensation and benefits of all kinds awardable to directors in respect of 2025 The amounts to be awarded to directors in respect of 2025 will be determined in accordance with the principles described above in “— Compensation policy for corporate officers — Compensation policy for directors.” Compensation and benefits of all kinds awardable in respect of 2025 to the Chairman of the Board of Directors The components of compensation awardable to the Chairman of the Board of Directors are described above in “— Compensation policy for corporate officers — Compensation policy for the Chairman of the Board of Directors.” Acting on a recommendation from the Compensation Committee, the Board of Directors meeting of February 12, 2025 decided to maintain the amount of compensation payable to the Chairman of the Board of Directors at €880,000 gross. The Chairman of the Board of Directors does not receive any variable compensation, stock options or performance shares, in accordance with AMF recommendations. Nor does he receive any compensation (i) for serving as a director or (ii) from any company included in San